Literature DB >> 11957058

Matrix metalloproteinase 9 in mucosally invasive gastric cancer.

Akihito Torii1, Yasuhiro Kodera, Masafumi Ito, Yasuhiro Shimizu, Takashi Hirai, Kenzo Yasui, Takeshi Morimoto, Yoshitaka Yamamura, Tomoyuki Kato, Taro Hayakawa, Noboru Fujimoto, Tsuyoshi Kito.   

Abstract

BACKGROUND: Matrix metalloproteinase 9 (MMP-9) facilitates tumor invasion and metastasis via basement membrane degradation. Control of MMP-9 production by cancer-stromal cell interactions in these processes has been observed.
METHODS: We measured plasma MMP-9 concentrations, using a one-step sandwich enzyme immunoassay, and also immunohistochemically localized MMP-9 in patients with small gastric cancers limited to the mucosa. The cancers were classified as intraepithelial tumor (Tis) and T1 disease according to the tumor-node-metastasis (TNM) classification of the International Union Against Cancer.
RESULTS: Patients with T1 disease had a higher positivity rate for and mean value of MMP-9 than patients with Tis disease. In T1 tumors, MMP-9 expression determined immunohistochemically, was greater in cells in cancer stroma than in cells in noncancerous stroma, a situation found in only a few Tis tumors.
CONCLUSIONS: These results suggest that MMP-9 is related to the initial step of gastric cancer invasion.

Entities:  

Year:  1998        PMID: 11957058     DOI: 10.1007/s101200050008

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  6 in total

1.  Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques.

Authors:  Bryan J Dicken; Kathryn Graham; Stewart M Hamilton; Sam Andrews; Raymond Lai; Jennifer Listgarten; Gian S Jhangri; L Duncan Saunders; Sambasivarao Damaraju; Carol Cass
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

2.  MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Authors:  J Mrena; J-P Wiksten; S Nordling; A Kokkola; A Ristimäki; C Haglund
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

3.  Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.

Authors:  Qi Gao; Yijun Wang; Jiaying Hou; Qizheng Yao; Ji Zhang
Journal:  J Comput Aided Mol Des       Date:  2017-06-16       Impact factor: 3.686

4.  Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer.

Authors:  Tsann-Long Hwang; Li-Yu Lee; Chee-Chan Wang; Ying Liang; Shu-Fang Huang; Chi-Ming Wu
Journal:  Exp Ther Med       Date:  2010-07-12       Impact factor: 2.447

5.  Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.

Authors:  F J G M Kubben; C F M Sier; W van Duijn; G Griffioen; R Hanemaaijer; C J H van de Velde; J H J M van Krieken; C B H W Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

6.  Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.

Authors:  Y Tanioka; T Yoshida; T Yagawa; Y Saiki; S Takeo; T Harada; T Okazawa; H Yanai; K Okita
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.